検索結果

Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica

in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Japan Completed jRCT2031250103 Dry Eye Dise...

ent Senju Pharmaceutical Co., Ltd. Mochida Pharmaceutical Co., Ltd. Launch of “Avarept® Ophthalmic Suspension 0.3%” in Japan, A Novel Treatment of Dry Eye Disease through TRPV1 Inhibition Senju Pharma...

临床试验信息 | 研究与开发 | 千寿制药株式会社

in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Japan Completed jRCT2031250103 Dry Eye Dise...

Clinical Trial Summaries | Research & Development | SENJU Pharmaceutica

in order of date of first publication Medical Condition Phase Project Code Country Recruitment Status Access to Trial ID Allergic Conjunctivitis 2 SJP-0049 Japan Completed jRCT2031250103 Dry Eye Dise...

Our Initiatives for Society/Environment | About Senju | SENJU Pharmaceutical

Communications with Customers and Provision of Information to Senju Pharmaceutical has a Customer Service Center for directly responding to inquiries from consumers and patients. The role of the Cente...